Articles published in Journal of Stem Cell Research & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Stem Cell Research & Therapy has got h-index 33, which means every article in Journal of Stem Cell Research & Therapy has got 33 average citations.
Following are the list of articles that have cited the articles published in Journal of Stem Cell Research & Therapy.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
22 | 58 | 59 | 65 | 23 | 13 | 36 | 34 | 49 | 63 | 101 | 62 | 44 | 26 |
Research, Review articles and Editorials |
2 | 4 | 1 | 2 | 12 | 12 | 29 | 28 | 44 | 56 | 80 | 48 | 12 | 19 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
20 | 54 | 58 | 63 | 11 | 1 | 7 | 6 | 5 | 7 | 21 | 14 | 32 | 6 |
Conference proceedings |
0 | 40 | 12 | 37 | 0 | 0 | 145 | 138 | 95 | 63 | 154 | 72 | 54 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
522 | 678 | 761 | 838 | 697 | 626 | 613 | 599 | 538 | 478 | 262 | 142 | 31 | 69 |
Journal total citations count | 6793 |
Journal impact factor | 1.64 |
Journal 5 years impact factor | 1.70 |
Journal cite score | 11.56 |
Journal h-index | 33 |
Self-renewal capacity of double negative 3 (DN3) early thymocytes preserves thymus autonomous function but compromises the ?-selection checkpoint
Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation
Human Pluripotent Stem Cells and CRISPR-Cas9 Genome Editing to Model Diabetes
Re-educating immunity in respiratory allergies: the potential for hematopoietic stem cell-mediated gene therapy
Towards safe therapy for immunodeficiency
Update on clinical ex vivo hematopoietic stem cell gene therapy for inherited monogenic diseases
Innovative cell-based therapies and conditioning to cure RAG deficiency
Gene replacement of ?-globin with ?-globin restores hemoglobin balance in ?-thalassemia-derived hematopoietic stem and progenitor cells
An integrated transcriptional switch at the ?-selection checkpoint determines T cell survival, development and leukaemogenesis
Laboratory-scale lentiviral vector production and purification for enhanced ex vivo and in vivo genetic engineering
Preclinical development of autologous hematopoietic stem cell-based gene therapy for immune deficiencies: A journey from mouse cage to bed side
Advances in gene therapy for hematologic disease and considerations for transfusion medicine
Gene Editing for the Treatment of Primary Immunodeficiency Diseases
CRISPR-Cas9 Gene Editing of Hematopoietic Stem Cells from Patients with Friedreich's Ataxia
CRISPR-CAS9. El mayor avance en técnicas de edición genética requiere una reflexión ética.
Genome editing for blood disorders: state of the art and recent advances
CIRM alpha stem cell clinics: collaboratively addressing regenerative medicine challenges
Mouse models in hematopoietic stem cell gene therapy and genome editing
Thymocyte self-renewal and oncogenic risk in immunodeficient mouse models: relevance for human gene therapy clinical trials targeting haematopoietic stem cell …
Humanized mouse models reveal an immunologic classification of idiopathic CD4 lymphocytopenia subtypes